Japan OTC Drug Deregulation Leads To Hot Price Competition
This article was originally published in PharmAsia News
Executive Summary
Deregulation of over-the-counter drugs in Japan appears to have had the government's desired effect as stores do battle in competition over prices. One supermarket, newly allowed to sell certain OTC drugs such as painkillers and cold remedies, became the latest to join the competition by announcing it would cut prices of such products by as much as 55 percent. Drug stores, also now allowed to sell most OTC drugs without having to have a pharmacist on the premises, also have joined the battle by offering discounts and extending store hours. (Click here for more - a subscription may be required
You may also be interested in...
Investors Go Berserk For Viking, Putting It Top Of Q1 Winners
The top 10 biggest share price winners and losers in Q1 from Evaluate show the investor frenzy for obesity drugs continues, while companies with governance doubts see shareholders retreat.
EU Consults On What Constitutes Personal & Commercially Confidential Data In Marketing Applications
Based on their experience with dealing with requests for access to documents over the past 12 years, EU regulators have proposed updating their guideline that provides for a harmonized approach to protecting personal data and business secrets in marketing authorization applications.
Industry & Regulators To Align Advice on COVID-19 Vaccine Updates
A multi-stakeholder workshop looked at the data needed to support updates to vaccine composition and the time required by manufacturers to update their vaccines, change their manufacturing processes and prepare approval applications.